论文信息 - Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer - 字舞流文

Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

S. Loi | V. Karantza | H. Rugo | R. Salgado | A. Tan | P. Ott | Philippe Bédard | S. Piha-Paul | S. Im | J. Sachdev | J. Delord | A. Varga | S. Saraf | E. V. van Brummelen | C. Tourneau | Dina Pietrangelo | E. van Brummelen